{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Most imported drugs are counterfeit knockoffs that could seriously endanger the health of those taking them, say federal drug and customs officials who conducted a spot inspection over the summer that they disclosed yesterday. The inspection ''illustrates the real and serious public health risks created by the importation of unapproved drugs,'' said Mark B. McClellan, commissioner of the Food and Drug Administration.", "headline": {"main": "F.D.A. Faults Quality of Imported Drugs"}, "abstract": "Federal drug and customs officials say most imported drugs are counterfeit knockoffs that could seriously endanger health of those taking them; Food and Drug Administration commissioner Mark B McClellan says spot inspection over summer illustrates real and serious public health risks created by importation of unapproved drugs; associate commissioner William K Hubbard says proposals in Congress to legalize drug imports would encourage buying of drugs that nobody has any regulatory authority over (M)", "print_page": "2", "word_count": 704, "_id": "4fd296aa8eb7c8105d872beb", "snippet": "Most imported drugs are counterfeit knockoffs that could seriously endanger the health of those taking them, say federal drug and customs officials who conducted a spot inspection over the summer that they disclosed yesterday.    The inspection...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/09/30/business/fda-faults-quality-of-imported-drugs.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MCCLELLAN, MARK B"}, {"name": "persons", "value": "HUBBARD, WILLIAM K"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "CUSTOMS SERVICE"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "COUNTERFEIT MERCHANDISE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gardiner", "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2003-09-30T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 1, "offset": 0, "time": 31}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}